SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-042000
Filing Date
2011-04-29
Accepted
2011-04-29 16:05:15
Documents
9
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f58985e10vq.htm 10-Q 313019
2 EX-31.1 f58985exv31w1.htm EX-31.1 8073
3 EX-31.2 f58985exv31w2.htm EX-31.2 8587
4 EX-32.1 f58985exv32w1.htm EX-32.1 4636
  Complete submission text file 0000950123-11-042000.txt   1389487

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT nktr-20110331.xml EX-101.INS 122101
6 EX-101 SCHEMA DOCUMENT nktr-20110331.xsd EX-101.SCH 10426
7 EX-101 CALCULATION LINKBASE DOCUMENT nktr-20110331_cal.xml EX-101.CAL 33656
8 EX-101 LABELS LINKBASE DOCUMENT nktr-20110331_lab.xml EX-101.LAB 101677
9 EX-101 PRESENTATION LINKBASE DOCUMENT nktr-20110331_pre.xml EX-101.PRE 66173
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 11794669
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1